Science, medicine, and the future: Cellular immunotherapy for cancer
- 1 December 2001
- Vol. 323 (7324), 1289-1293
- https://doi.org/10.1136/bmj.323.7324.1289
Abstract
Methods All three authors are involved in research into cellular immunotherapy and gene therapy. We searched PubMed and Medline databases using the terms “cancer vaccines,” “dendritic cells,” and “lymphocyte therapy.” Review articles Pardoll D .Cancer vaccines. Nat Med 1998;4:525–31. Greten TF .Cancer vaccines. J Clin Oncol 1999;17:1047–60.Keywords
This publication has 16 references indexed in Scilit:
- Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine, 2000
- Multicenter, Randomized, Phase III Trial of CD8+ Tumor-Infiltrating Lymphocytes in Combination With Recombinant Interleukin-2 in Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 1999
- Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.1999
- Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trialThe Lancet, 1999
- Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene TransferJournal of Urology, 1998
- Adjuvant therapy of renal cell carcinoma with active-specific-immunotherapy (ASI) using autologous tumor vaccine.1997
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Aldesleukin (recombinant interleukin-2): a review of its pharmacological properties, clinical efficacy and tolerability in patients with renal cell carcinoma.1997
- Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.1996
- Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic MelanomaaAnnals of the New York Academy of Sciences, 1993